Fundraise / allotmentFiled on BSE ·

Natco Pharma Limited receives in-principle approval for Rights Issue

Natco Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • Approval received from National Stock Exchange of India Limited and BSE Limited on 21st September 2026
  • Rights Issue involves fully paid-up equity shares of the company
  • Copies of approval letters are available on the company's website at the specified URL

Original filing

Receipt Of In-Principal Approval For Rights Issue Of Equity Shares

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies

Electrical Equipment

Revenue: Rank 1Margin: Rank 1

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Natco Pharma

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.